Variation exists in the resource categories included in economic evaluations, and National Institute for Health and Care Excellence (NICE) guidance suggests the inclusion only of costs related to the index condition or intervention.

Cost categories included in an economic evaluation of stable coronary artery disease significantly impact on estimates of cost effectiveness and decision uncertainty.